CTNM Overview

Company Profile

Related stocks

CBIO • United States

Crescent Biopharma, Inc.

14.91 USD

553.86M USD 1Y +17.1%

ACRS • United States

Aclaris Therapeutics, Inc.

3.83 USD

563.77M USD 1Y +99.5%

XOMA • United States

XOMA Royalty Corporation

40.17 USD

710.16M USD

ABUS • United States

Arbutus Biopharma Corporation

4.22 USD

646.82M USD 1Y +0%

ALLO • United States

Allogene Therapeutics, Inc.

1.46 USD

504.42M USD 1Y -4.8%

RGNX • United States

REGENXBIO Inc.

8.07 USD

532.73M USD 1Y -33.8%

ZVRA • United States

Zevra Therapeutics, Inc.

11.39 USD

676.38M USD 1Y +3.4%

SGP • United States

SpyGlass Pharma, Inc.

24.92 USD

833.52M USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

81.5% p.a.

Max Drawdown (3Y)

-84.4%

Sharpe Ratio (3Y)

-0.10

Beta Factor

0.86

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections